![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
B-Cell Prolymphocytic Leukemia medications
In this page you will find the list of drugs approved by the FDA to treat B-Cell Prolymphocytic Leukemia.
alemtuzumab (Campath)
Monoclonal Antibodies
Learn More arrow_right_alt
cladribine (Leustatin)
Chemotherapy Agents
Learn More arrow_right_alt
cytarabine (Cytosar-U)
Chemotherapy Agents
Learn More arrow_right_alt
Famciclovir (Famvir)
Antiviral/Antineoplastic Agents
Learn More arrow_right_alt
ibrutinib (Imbruvica)
Tyrosine Kinase Inhibitors
Learn More arrow_right_alt
mitoxantrone (Novantrone)
Chemotherapy Agents
Learn More arrow_right_alt
nelarabine (Arranon)
Chemotherapy Agents
Learn More arrow_right_alt
Olaparib (Lynparza)
Targeted Therapies
Learn More arrow_right_alt
pentostatin (Nipent)
Chemotherapy Agents
Learn More arrow_right_alt
ruxolitinib (Jakafi, Jakavi, Opzelura)
Targeted Therapies
Learn More arrow_right_alt
Tofacitinib (Xeljanz)
Targeted Therapies
Learn More arrow_right_alt
trimethoprim (Bactrim, Septra)
Chemotherapy Agents
Learn More arrow_right_alt
venetoclax (Venclexta)
Targeted Therapies
Learn More arrow_right_alt
Together we care.
Together we cure.
100% of every dollar you give supports our life-changing mission.